Crisprtx
Develops CRISPR gene-editing medicines for people with serious diseases
Highlights
- Hiring2 open roles
- New on EvolcAdded 2026-11-14
Recent signals
What changed at Crisprtx in the last 6 months, newest first. Each line links to its public source.
- 14 Nov 2026 Leadership hire · Hiring Quality Site Head (Framingham) crisprtx.wd12.myworkdayjobs.com
- 10 Nov 2026 Publishing · Started publishing: 4 blog or news posts in 30 days crisprtx.com
About Crisprtx
CRISPR Therapeutics develops gene-based medicines using CRISPR/Cas9 gene editing. Its programs span hemoglobinopathies, oncology, autoimmune diseases, cardiovascular disease, diabetes and regenerative medicine.
The company’s therapy CASGEVY, co-developed with Vertex Pharmaceuticals, is approved in some countries for eligible patients with sickle cell disease or transfusion-dependent beta thalassemia. Its pipeline includes clinical and preclinical programs.
Founded in 2013, CRISPR Therapeutics has its global headquarters in Zug, Switzerland, and R&D headquarters in Boston. It also has a manufacturing facility in Framingham and an R&D hub in San Francisco.
Product: Gene-edited medicines, including CRISPR/Cas9 therapies for serious diseases.
Jobs at Crisprtx (2)
Crisprtx is hiring for 2 roles in manufacturing and operations, based in Framingham.
Senior Specialist, Site Supply Chain Planning
New on EvolcQuality Site Head
New on Evolc
More biotech & pharma companies
Debiopharm
Develops and licenses medicines for pharmaceutical partners and invests in digital health venturesPharvaris
Develops oral therapies for people with hereditary and other bradykinin-mediated angioedemaNew on EvolcRidgelinediscovery
Creates and operates new drug discovery biotech companies with academic founders, backed by Versant Ventures, from BaselRoche
Diagnostics, medicines and digital health solutions for patients and healthcare professionals worldwideRoche
Diagnostics, medicines and digital health solutions for patients and healthcare systems worldwideSalary transparentSiegfried
Contract development and manufacturing of APIs and drug products for pharmaceutical companies
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- nginxHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Privacy & consent
- OneTrustHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.